Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchcancer-testis antigensimmuno-oncologypeptide vaccines

Review maps cancer-testis antigens as immuno-oncology targets

Journal of Immunology Research authors summarize mechanisms, therapeutic strategies and clinical prospects for cancer-testis antigen approaches.

PR
By Priya Raman · Science Reporter
Dec 31 19:00 ETSource: Journal of immunology research

The wire

  1. 01Shi and colleagues reviewed cancer-testis antigens in immuno-oncology, covering mechanisms and therapeutic strategies.
  2. 02Such antigens underpin peptide vaccine and cell therapy development in oncology.
  3. 03Clinical readouts and lead candidates are not specified in the excerpt.

From the source

Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives

Journal of immunology research · 2026 · Shi R, Ran L, Song T et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42753002/